Terumo 4543.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4543.T. It has been listed since 21 June 1982. In the fiscal year to 31 March 2026, it reported revenue of ¥1.13trn and net income of ¥135.91bn. At that date it held total assets of ¥2.31trn and shareholders' equity of ¥1.58trn.

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. The company is headquartered in Shibuya-Ku, Tokyo-To. The firm operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Toshiaki TakagiChairman of the Board, Representative Director, since 2010¥137.0m
• Mr. Hikaru SamejimaPresident, Chief Executive Officer, Representative Director, since 2014
• Mr. Jin HagimotoChief Financial Officer, Executive Officer, Manager of CFO Office
• Ms. Tomoko AdachiChief Human Resource Officer, Executive Officer
• Mr. Shinji OmoriChief Technology Officer, Executive Officer, Manager of DX Promotion Office
• Mr. Toshihiko OsadaSenior Managing Executive Officer, Director, since 2016
• Mr. Antoinette GawinSenior Managing Executive Officer, President of Blood System Company, President & Chief Executive Officer of Subsidiary
• Mr. Kazunori HiroseManaging Executive Officer, Director, since 2016
• Mr. Norimasa KunimotoManaging Executive Officer, Director, since 2018
• Mr. Fumihisa HiroseManaging Executive Officer, President of Cardiac and Vascular Company, President of TIS Division of Cardiac and Vascular Company, since 2024
• Mr. Itaru SakaguchiManaging Executive Officer, President of Medical Care Solutions Company
• Mr. Jin NishizakiExecutive Officer, Chief Director of Domestic Sales

Overall

93

Environment

99

Social

99

Governance

80

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.